PATENT CLAIM ANALYSIS

Application Number: 15953109
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-03
Patent Classification: ["514", "210180"]

Abstract:
The present invention relates to compounds of formula I shown below: wherein Q is as defined herein. The compounds of formula I act as selective positive allosteric modulators of strychnine-sensitive alpha 1-glycine receptors. The present invention further relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of diseases or conditions in which strychnine-sensitive alpha 1-glycine receptor activity is implicated (such as, for example, chronic pain. The present invention also relates to processes for the preparation of these compounds and to pharmaceutical compositions comprising them.

Claim (Index 1):
A compound of formula (I) shown below: wherein: Q is: wherein:  indicates the point of attachment to the C(\u2550O) moiety of the compound of formula I; R 1 , R 2a , R 2b  and R 3  are each independently selected from hydrogen, halo, methyl, hydroxymethyl, CF 3  and OCF 3 ; or R 2a  and R 2b  are linked such that together they form a 4, 5 or 6-membered carbocyclic or heterocyclic ring; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.63333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15587068', '15107653', '15641751', '13360029', '12498185']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812698071182698
- 35 USC 102 Novelty (BERT): 0.5811453669742501
- Combined Prediction Score: 0.7612573631038678
- Mean Citation Score: 377.02693
- Max Citation Score: 518.12714
- Similarity Product: 359.8711539512349

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test